Medical archives (Sarajevo, Bosnia and Herzegovina) · 2025
Hypoxic Conditioned Medium Secretome from Mesenchymal Stem Cell Alleviates Sepsis by Targeting IL-6 and IL-4.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sari Mutiara Indah, Jusuf Nelva Karmila, Munir Delfitri, Putra Agung, Bisri Tatang, Ilyas Syafruddin, Farhat Farhat, Muhar Adi Muradi
Аннотация
BACKGROUND: Sepsis is a state of immune response imbalance in an attempt to eliminate infection. Currently, the hypoxic conditioned medium (HPO-CM) secretome from mesenchymal stem cells (MSCs) has been considered as a therapeutic approach with their immunomodulatory capabilities.
OBJECTIVE: The aim of this article was to study the effect of HPO-CM secretome on the levels of IL-6 and IL-4 in the rat model of sepsis.
METHODS: Forty-eight male Rattus norvegicus rats aged 10-12 weeks were divided into four groups: sham (no sepsis induction and treatment), control (sepsis induction without treatment), T1 (sepsis induction and treated with 150 µL of HPO-CM secretome), and T2 (sepsis induction and treated with 300 µL of HPO-CM secretome). Sepsis was induced with procedures based on previous studies. Forty-eight hours after sepsis induction, we sacrificed the rats and collected the blood from the rat orbitals to examine the serum IL-6 and IL-4 levels.
RESULTS: A significant decrease in IL-6 levels was found in rats given 150 µL and 300 µL of HPO-CM secretome. Meanwhile, a significant increase in IL-4 levels was found in rats given 300 µL of HPO-CM secretome.
CONCLUSION: HPO-CM secretome can alleviate immune dysregulation in sepsis by reducing serum IL-6 levels and increasing serum IL-4 levels.
OBJECTIVE: The aim of this article was to study the effect of HPO-CM secretome on the levels of IL-6 and IL-4 in the rat model of sepsis.
METHODS: Forty-eight male Rattus norvegicus rats aged 10-12 weeks were divided into four groups: sham (no sepsis induction and treatment), control (sepsis induction without treatment), T1 (sepsis induction and treated with 150 µL of HPO-CM secretome), and T2 (sepsis induction and treated with 300 µL of HPO-CM secretome). Sepsis was induced with procedures based on previous studies. Forty-eight hours after sepsis induction, we sacrificed the rats and collected the blood from the rat orbitals to examine the serum IL-6 and IL-4 levels.
RESULTS: A significant decrease in IL-6 levels was found in rats given 150 µL and 300 µL of HPO-CM secretome. Meanwhile, a significant increase in IL-4 levels was found in rats given 300 µL of HPO-CM secretome.
CONCLUSION: HPO-CM secretome can alleviate immune dysregulation in sepsis by reducing serum IL-6 levels and increasing serum IL-4 levels.